Table: Fuji Pharmaceutical -2021/22 group results

Fuji Pharma

10/11/2022 08:00

Nov 10 (Reuters)- 
          Fuji Pharmaceutical  Co Ltd 
          CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)
                 Year ended      Year ended       Year to       NEXT   
              Sep 30, 2022    Sep 30, 2021   Sep 30, 2023     YEAR     
                 LATEST         YEAR-AGO        COMPANY      COMPANY   
                 RESULTS         RESULTS       FORECAST    H1 FORECAST 
  Sales           35.43           33.99          43.31        20.14    
               (+4.2 pct)      (+0.6 pct)     (+22.3 pct)  (+13.6 pct) 
  Operating        3.78            3.35           4.05         2.00    
               (+12.8 pct)     (+6.7 pct)     (+7.2 pct)   (-26.1 pct) 
  Recurring        3.73            3.25           4.09         2.02    
               (+14.6 pct)     (+9.0 pct)     (+9.7 pct)   (-29.4 pct) 
  Net
  Net              2.70            2.43           2.97         1.48    
               (+10.9 pct)     (+16.6 pct)    (+10.3 pct)  (-19.5 pct) 
  EPS          111.01 yen       90.54 yen     122.42 yen    60.76 yen  
  Ann Div       35.00 yen       29.00 yen      37.00 yen               
  -Q2 Div       15.00 yen       14.00 yen      17.00 yen               
  -Q4 Div       20.00 yen       15.00 yen      20.00 yen               
  
  NOTE - Fuji Pharmaceutical  Co Ltd.
  *Second Net profit row denotes profit attributable to owners ofthe parent 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4554.T